Ann: Quarterly Activities & Cashflow Report, page-2

ASX ANNOUNCEMENT

22 January 2024
Quarterly Activities & Appendix 4C December 2023

● Biome reports record $3.3m sales revenue and $3.07m cash receipts in Q2 FY24
● Biome records first ever quarter of positive operating cash flow of $81k
● Underlying cash flow improved by $500k compared to the previous quarter
● Record cash receipts in Q2 FY24, up 45% to $3.07m, accounts receivable increased
from $2.08m to $2.28m
● Landmark agreement signed in Q2 FY24 to develop company owned IP
● Biome reaffirms it is sufficiently funded to execute its FY24 strategy
Microbiome health company Biome Australia Limited (ASX: BIO) (‘Biome’ or ‘the
company’) is pleased to provide its Appendix 4C and Activity Report for the quarter ended
31 December 2023.
Biome reports record sales revenue of $3.3m for the quarter while maintaining a gross
margin of 59%. This represents an 83.3% increase in quarterly sales revenue compared to
the previous corresponding period (PCP).


Cracking report